Daré Bioscience reviews first quarter results in earnings call

Daré Bioscience held its earnings call for the first quarter of 2026 on May 14 to discuss financial results and business updates focused on women's health products.

Daré Bioscience, Inc. hosted the conference call at 4:30 PM EDT to cover results for the quarter ended March 31, 2026. Chief Accounting Officer MarDee Haring-Layton opened the session and introduced CEO Sabrina Johnson as the main participant alongside her.

Relaterte artikler

Cytek Biosciences released its financial results for the first quarter of 2026 on May 7. The company then hosted an earnings conference call the same day at 4:30 PM EDT.

Rapportert av AI

BioMarin Pharmaceutical Inc. conducted its first-quarter 2026 earnings conference call on May 4, 2026. Company executives, including CEO Alexander Hardy, presented financial results and updates. The call included forward-looking statements and non-GAAP measures.

Core Scientific, Inc. published a slide deck for its first-quarter 2026 earnings call on May 6.

Rapportert av AI

Illumina Inc. conducted its first-quarter 2026 earnings conference call on April 30, 2026, at 4:30 PM EDT. CEO Jacob Thaysen and CFO Ankur Dhingra presented updates on the business and financial results. The company released its earnings after market close, available on its investor relations website.

 

 

 

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis